Learn, Analyse & Invest
only with
only with
+91
Download Orca
Ajanta Pharma Ltd.
Ajanta Pharma
Ajanta Pharma Ltd. live price is ₹ 0.00. Price change 0.00, 0.00 percent.
₹ 0.00
0.00 (0.00)%
Healthcare
Mid-cap - With a market cap of ₹412.11 Cr.
| EX-Date | Purpose |
|---|---|
| 30 04 2021 | Audited Results |
| 29 07 2021 | Quarterly Results |
| 29 10 2021 | Interim Dividend & Quarterly Results |
| 28 12 2021 | Buy Back of Shares |
| 31 01 2022 | Quarterly Results |
| 10 05 2022 | Bonus issue & Audited Results |
| 28 07 2022 | Quarterly Results |
| 03 11 2022 | Quarterly Results & Interim Dividend |
| 01 02 2023 | Quarterly Results |
| 10 03 2023 | Buy Back of Shares |
| 05 05 2023 | Audited Results |
| 27 07 2023 | Interim Dividend & Quarterly Results |
| 27 07 2023 | Quarterly Results |
| 31 10 2023 | Quarterly Results |
| 31 01 2024 | Second Interim Dividend & Quarterly Results |
| 28 10 2024 | Quarterly Results |
| 30 01 2025 | Quarterly Results |
| 30 04 2025 | A.G.M. & Audited Results |
| 28 07 2025 | Quarterly Results |
| 03 11 2025 | Quarterly Results & Interim Dividend |
| 30 01 2026 | Quarterly Results |
| 05 05 2026 | Audited Results & Quarterly Results |
| 30 07 2026 | Quarterly Results & Interim Dividend |
News
15-OCT-2026
Ajanta Pharma informs about board meeting
03:20 PM
15-OCT-2026
Ajanta Pharma informs about newspaper advertisement
11:34 AM
28-SEP-2026
Ajanta Pharma informs about closure of trading window
11:47 AM
25-SEP-2026
Ajanta Pharma informs about closure of trading window
11:55 AM
31-AUG-2026
Ajanta Pharma informs about newspaper publication
11:07 AM
31-JUL-2026
Ajanta Pharma - Quaterly Results
12:00 AM
30-JUL-2026
Ajanta Pharma reports Profit after tax of Rs 3154.70 Mln, in the June 2026 quarter
02:38 PM
20-JUL-2026
Ajanta Pharma informs about conference call
05:13 PM
20-JUL-2026
Ajanta Pharma informs about board meeting
12:26 PM
14-JUL-2026
Ajanta Pharma informs about substantial acquisition of shares & takeovers
11:20 AM
07-JUL-2026
Ajanta Pharma informs about certificate
12:14 PM
03-JUL-2026
Ajanta Pharma informs about disclosures
03:41 PM
03-JUL-2026
Ajanta Pharma informs about disclosure
12:41 PM
02-JUL-2026
Ajanta Pharma gets EIR from USFDA for manufacturing facility at Paithan
The cGMP inspection of the Paithan facility was conducted by the USFDA from April 13, 2026 to April 21, 2026
04:00 PM
18-JUN-2026
Ajanta Pharma informs about annual report
12:14 PM
17-JUN-2026
Ajanta Pharma informs about press release
03:21 PM
15-JUN-2026
Ajanta Pharma informs about AGM
09:41 AM
10-JUN-2026
Ajanta Pharma trades higher on the bourses
The company’s promoter has sold stake worth Rs 1023.96 crore
03:03 PM
10-JUN-2026
Ajanta Pharma’s promoter sells stake worth Rs 1023.96 crore
Ravi Agrawal Trust has sold 34.50 lakh equity shares, representing 2.76% of total shareholding, of the company
02:58 PM
09-JUN-2026
Ajanta Pharma informs about disclosure
11:07 AM
09-JUN-2026
Ajanta Pharma informs about SAST updates
11:05 AM
02-JUN-2026
Ajanta Pharma informs about disclosure
11:12 AM
12-MAY-2026
Ajanta Pharma informs about secretarial compliance report
03:01 PM
06-MAY-2026
Ajanta Pharma - Quaterly Results
12:00 AM
05-MAY-2026
Ajanta Pharma reports Profit after tax of Rs 1972.80 Mln, in the March 2026 quarter
03:24 PM
22-APR-2026
USFDA concludes inspection at Ajanta Pharma’s Paithan manufacturing facility
The inspection was conducted from April 13, 2026, to April 21, 2026
10:10 AM
22-APR-2026
Ajanta Pharma informs about updates
09:41 AM
09-MAR-2026
Ajanta Pharma informs about analyst meet
10:10 AM
06-MAR-2026
Ajanta Pharma informs about disclosure
02:47 PM
05-FEB-2026
Ajanta Pharma informs about earnings call transcript
05:31 PM
02-FEB-2026
Ajanta Pharma informs about analyst meet
12:47 PM
02-FEB-2026
Ajanta Pharma informs about newspaper publication
12:44 PM
31-JAN-2026
Ajanta Pharma - Quaterly Results
12:00 AM
30-JAN-2026
Ajanta Pharma reports Profit after tax of Rs 2450.40 Mln, in the December 2025 quarter
03:03 PM
13-JAN-2026
Ajanta Pharma incorporates wholly owned subsidiary in Ireland
The wholly owned subsidiary has been incorporated in Ireland for the purpose of carrying on the business of pharmaceutical products
04:26 PM
12-JAN-2026
Ajanta Pharma informs about earnings conference call
04:53 PM
24-DEC-2025
Ajanta Pharma shines on entering into in-licensing agreement with Biocon
Semaglutide, the GLP-1 receptor agonist, is to improve glycaemic control in adults
11:35 AM
24-DEC-2025
Ajanta Pharma enters into in-licensing agreement with Biocon
Semaglutide, the GLP-1 receptor agonist, is to improve glycaemic control in adults
10:12 AM
19-DEC-2025
Ajanta Pharma informs about disclosures
04:37 PM
06-NOV-2025
Ajanta Pharma informs about transcript of earnings call
09:29 AM
04-NOV-2025
Ajanta Pharma - Quaterly Results
12:00 AM
03-NOV-2025
Ajanta Pharma reports Profit after tax of Rs 2495.30 Mln, in the September 2025 quarter
01:25 PM
24-OCT-2025
Ajanta Pharma informs about update on board meeting
10:04 AM
03-OCT-2025
Ajanta Pharma informs about updates
05:34 PM
16-SEP-2025
Ajanta Pharma inform about disclosure
12:21 PM
02-SEP-2025
Ajanta Pharma informs about analyst meet
10:46 AM
29-JUL-2025
Ajanta Pharma informs about press release
03:41 PM
28-JUL-2025
Ajanta Pharma - Quaterly Results
02:59 PM
28-JUL-2025
Ajanta Pharma reports Profit after tax of Rs 2549.70 Mln, in the June 2025 quarter
02:59 PM
28-JUL-2025
Ajanta Pharma - Quaterly Results
02:59 PM
28-JUL-2025
Ajanta Pharma - Quaterly Results
02:59 PM
18-JUL-2025
Ajanta Pharma informs about outcome of AGM
04:57 PM
08-JUL-2025
Ajanta Pharma informs about certificate
09:56 AM
19-JUN-2025
Ajanta Pharma informs about disclosure
12:49 PM
17-JUN-2025
Ajanta Pharma informs about disclosure
01:15 PM
12-MAY-2025
Ajanta Pharma informs about annual secretarial compliance report
01:06 PM
05-MAY-2025
Ajanta Pharma informs about written transcript of earnings call
05:23 PM
02-MAY-2025
Ajanta Pharma informs about newspaper publication
11:48 AM
30-APR-2025
Ajanta Pharma - Quaterly Results
03:23 PM
30-APR-2025
Ajanta Pharma reports Profit after tax of Rs 1934.30 Mln, in the March 2025 quarter
03:23 PM
30-APR-2025
Ajanta Pharma - Quaterly Results
03:23 PM
30-APR-2025
Ajanta Pharma - Quaterly Results
03:23 PM
21-MAR-2025
Ajanta Pharma to expand manufacturing capacity
The investments required for the capacity addition is Rs 92 crore
02:09 PM
20-MAR-2025
Ajanta Pharma informs about updates
05:26 PM
11-MAR-2025
Ajanta Pharma informs about disclosure
12:01 PM
14-FEB-2025
Ajanta Pharma informs about disclosure
11:53 AM
07-FEB-2025
Ajanta Pharma informs about analyst meet
10:00 AM
04-FEB-2025
Ajanta Pharma informs about clarification on market price movement
10:12 AM
30-JAN-2025
Ajanta Pharma - Quaterly Results
03:35 PM
30-JAN-2025
Ajanta Pharma reports Profit after tax of Rs 2524.50 Mln, in the December 2024 quarter
03:35 PM
30-JAN-2025
Ajanta Pharma - Quaterly Results
03:35 PM
30-JAN-2025
Ajanta Pharma - Quaterly Results
03:35 PM
28-OCT-2024
Ajanta Pharma - Quaterly Results
03:51 PM
28-OCT-2024
Ajanta Pharma reports Profit after tax of Rs 2349.80 Mln, in the September 2024 quarter
03:51 PM
28-OCT-2024
Ajanta Pharma - Quaterly Results
03:51 PM
28-OCT-2024
Ajanta Pharma - Quaterly Results
03:51 PM
15-APR-2024
Ajanta Pharma informs about compliance certificate
04:53 PM
30-MAR-2024
Ajanta Pharma informs about disclosure
03:27 PM
31-JAN-2024
Ajanta Pharma - Quaterly Results
04:12 PM
31-JAN-2024
Ajanta Pharma reports Profit after tax of Rs 2201.50 Mln, in the December 2023 quarter
04:12 PM
31-JAN-2024
Ajanta Pharma - Quaterly Results
04:12 PM
31-JAN-2024
Ajanta Pharma - Quaterly Results
04:12 PM
25-JAN-2024
Ajanta Pharma submits intimation of record date
12:53 PM
25-JAN-2024
Ajanta Pharma informs about update on board meeting
10:58 AM
19-DEC-2023
Ajanta Pharma informs about loss of share certificate
01:39 PM
15-DEC-2023
Ajanta Pharma informs about loss of share certificate
02:12 PM
15-DEC-2023
Ajanta Pharma informs about disclosure
12:22 PM
15-DEC-2023
Ajanta Pharma informs about revised disclosure
12:14 PM
24-NOV-2023
Ajanta Pharma informs about disclosures
05:05 PM
22-NOV-2023
Ajanta Pharma informs about loss of share certificate
10:43 AM
31-OCT-2023
Ajanta Pharma reports Profit after tax of Rs 2123.60 Mln, in the September 2023 quarter
02:15 PM
31-OCT-2023
Ajanta Pharma - Quaterly Results
02:15 PM
31-OCT-2023
Ajanta Pharma - Quaterly Results
02:15 PM
31-OCT-2023
Ajanta Pharma - Quaterly Results
02:15 PM
19-OCT-2023
Ajanta Pharma informs about board meeting
03:17 PM
27-SEP-2023
Ajanta Pharma informs about loss of share certificate
11:32 AM
04-SEP-2023
Ajanta Pharma informs about newspaper publication
11:06 AM
31-AUG-2023
Ajanta Pharma zooms on getting USFDA’s final nod for Topiramate Extended-Release Capsules
The company has received 50 final ANDA approvals, out of which 41 are commercialized
09:27 AM
30-AUG-2023
Ajanta Pharma gets USFDA’s final nod for Topiramate Extended-Release Capsules
The company has received 50 final ANDA approvals, out of which 41 are commercialized
06:15 PM
17-AUG-2023
Ajanta Pharma informs about investor meetings
10:12 AM
07-AUG-2023
Ajanta Pharma informs about details of loss of certificate
04:20 PM
27-JUL-2023
Ajanta Pharma informs about outcome of board meeting
04:51 PM
27-JUL-2023
Ajanta Pharma - Quaterly Results
03:52 PM
27-JUL-2023
Ajanta Pharma - Quaterly Results
03:52 PM
27-JUL-2023
Ajanta Pharma reports Profit after tax of Rs 1172.10 Mln, in the March 2023 quarter
03:52 PM
27-JUL-2023
Ajanta Pharma - Quaterly Results
03:52 PM
24-JUL-2023
Ajanta Pharma informs about conference call
12:08 PM
24-JUL-2023
Ajanta Pharma informs about board meeting
12:04 PM
21-JUL-2023
Ajanta Pharma informs about disclosure
02:44 PM
12-JUL-2023
Ajanta Pharma soars on inking partnership with Credible Innovations
The company has chosen Credible as its strategic and implementation partner to enhance its ESG performance
02:37 PM
11-JUL-2023
Ajanta Pharma inks partnership with Credible Innovations
The company has chosen Credible as its strategic and implementation partner to enhance its ESG performance
03:12 PM
03-JUL-2023
Ajanta Pharma to enhance presence across select geographies in Asia, Africa
It intends to rely on its strengths to grow faster in countries where it has a presence with its range of branded generics
12:09 PM
26-JUN-2023
USFDA completes inspection at Ajanta Pharma’s Dahej formulation facility
At the end of inspection, USFDA issued no Form 483 to the said facility
10:05 AM
26-JUN-2023
Ajanta Pharma informs about updates
09:33 AM
19-JUN-2023
Ajanta Pharma informs about newspaper publication
10:40 AM
14-JUN-2023
Ajanta Pharma informs about newspaper publication
12:38 PM
10-MAY-2023
Ajanta Pharma informs about annual secretarial compliance report
03:08 PM
05-MAY-2023
Ajanta Pharma - Quaterly Results
03:39 PM
05-MAY-2023
Ajanta Pharma - Quaterly Results
03:39 PM
05-MAY-2023
Ajanta Pharma - Quaterly Results
03:39 PM
05-MAY-2023
Ajanta Pharma reports Profit after tax of Rs 1172.10 Mln, in the March 2023 quarter
03:39 PM
27-APR-2023
Ajanta Pharma informs about board meeting
10:17 AM
21-APR-2023
Ajanta Pharma informs about disclosure
11:54 AM
10-APR-2023
Ajanta Pharma informs about certificate
10:53 AM
14-MAR-2023
Ajanta Pharma informs about buyback of shares
12:59 PM
10-MAR-2023
Ajanta Pharma informs about voting results of postal ballot
05:06 PM
24-FEB-2023
Ajanta Pharma informs about loss of share certificate
02:51 PM
13-FEB-2023
Ajanta Pharma informs about transcript of earnings call
10:45 AM
02-FEB-2023
Ajanta Pharma reports 30% fall in Q3 consolidated net profit
Total consolidated income of the company increased by 16.79% to Rs 1,006.70 crore for Q3FY23
11:29 AM
01-FEB-2023
Ajanta Pharma - Quaterly Results
03:36 PM
01-FEB-2023
Ajanta Pharma - Quaterly Results
03:36 PM
01-FEB-2023
Ajanta Pharma - Quaterly Results
03:36 PM
27-JAN-2023
Ajanta Pharma informs about disclosure
03:09 PM
23-JAN-2023
Ajanta Pharma informs about board meeting
12:09 PM
23-DEC-2022
Promoter entities sell 4.3% stake in Ajanta Pharma
The shares were offloaded at an average price of Rs 1,160.1 per scrip, taking the transaction value to Rs 637.22 crore
03:16 PM
21-DEC-2022
Ajanta Pharma informs about newspaper publication
03:24 PM
04-NOV-2022
Ajanta Pharma reports 20% fall in Q2 consolidated net profit
Total consolidated income of the company increased by 7.01% at Rs 978.45 crore for Q2FY23
11:50 AM
03-NOV-2022
Ajanta Pharma - Quaterly Results
03:39 PM
03-NOV-2022
Ajanta Pharma - Quaterly Results
03:39 PM
03-NOV-2022
Ajanta Pharma reports Profit after tax of Rs 1671.80 Mln, in the September 2022 quarter
03:39 PM
28-OCT-2022
Ajanta Pharma informs about earnings conference call
12:10 PM
13-OCT-2022
Ajanta Pharma informs about disclosure
12:21 PM
12-SEP-2022
Ajanta Pharma informs about updates
12:49 PM
12-SEP-2022
Ajanta Pharma gets 2 procedural observation from USFDA for Dahej unit
USFDA has conducted inspection at Dahej unit from September 05, 2022 to September 09, 2022
12:28 PM
12-SEP-2022
Ajanta Pharma informs about disclosure
10:55 AM
13-JUL-2022
Ajanta Pharma informs about disclosures
01:21 PM
13-JUL-2022
Ajanta Pharma informs about certificate
12:46 PM
07-JUL-2022
Ajanta Pharma informs about newspaper publication
02:53 PM
04-JUL-2022
Ajanta Pharma informs about newspaper publication
09:43 AM
13-JUN-2022
Ajanta Pharma informs about declaration of voting results of postal ballot
05:11 PM
13-JUN-2022
Ajanta Pharma informs about disclosure
04:59 PM